Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-randomised, Multicentre Study to Allow Continued Access to and Assess the Safety and Tolerability of AZD1775 for Patients Enrolled in AZD1775 Clinical Pharmacology Studies

NCT03313557 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03313557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-randomised, Multicentre Study to Allow Continued Access to and Assess the Safety and Tolerability of AZD1775 for Patients Enrolled in AZD1775 Clinical Pharmacology Studies
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
October 27, 2017
Completion date
May 17, 2019
Enrollment
48 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors